47324 Federal Register / Vol. 82, No. 195 / Wednesday, October 11, 2017 / Notices 

substances to which the mandatory 

minimum penalty applies? 

3. The Commission invites general 

comment on whether and, if so how, the 

guidelines should be amended to 

account for fentanyl and fentanyl 

analogues. How, if at all, should the 

guideline provisions related to fentanyl 

and the fentanyl analogues specifically 

listed in § 2D1.1 be amended? For 

example, should the Commission revise 

the marihuana equivalencies already 

provided for fentanyl, AlphaMethylfentanyl, and 3-Methylfentanyl? 

If so, what equivalency should the 

Commission provide for each substance, 

and why? 

Should the Commission amend 

§ 2D1.1 to account for other unlisted 

fentanyl analogues? For example, 

should the Commission establish 

marihuana equivalencies for fentanyl 

analogues currently not listed in 

§ 2D1.1? If so, what specific fentanyl 

analogues should the Commission 

include in the Drug Equivalency Tables 

and what equivalency should the 

Commission provide for each such 

substance? What factors should the 

Commission consider when deciding 

whether to account for these 

substances? 

4. The Commission has received 

anecdotal information about the 

availability of several fentanyl 

analogues. How are these novel fentanyl 

analogues developed, manufactured and 

trafficked? To what extent are these 

substances legally manufactured for 

pharmaceutical purposes and then 

diverted for illicit trafficking and use, as 

opposed to having been manufactured 

illegally? How complex is the procedure 

to develop these substances and how 

frequently are they introduced into the 

illicit drug market? 

Instead of providing marihuana 

equivalencies for individual fentanyl 

analogues, should the Commission 

consider establishing a single 

marihuana equivalency applicable to all 

fentanyl analogues? Are fentanyl 

analogues sufficiently similar to one 

another in chemical structure, 

pharmacological effects, potential for 

addiction and abuse, patterns of 

trafficking and abuse, and associated 

harms, to support the adoption of a 

broad class-based approach for 

sentencing purposes? If so, what 

marihuana equivalency should the 

Commission provide for fentanyl 

analogues as a class and why? What 

factors should the Commission account 

for if it considers adopting a broad classbased approach for fentanyl and its 

analogues? Should the Commission 

define ‘‘fentanyl analogues’’ for 

purposes of this broad class-based 

approach? If so, how? Are there any 

fentanyl analogues that should not be 

included as part of a broad class-based 

approach and for which the 

Commission should provide a 

marihuana equivalency separate from 

other fentanyl analogues? If so, what 

equivalency should the Commission 

provide for each such fentanyl analogue, 

and why? 

What are the advantages and 

disadvantages of a broad class-based 

approach for fentanyl analogues? If the 

Commission were to provide a different 

approach to account for fentanyl 

analogues in the guidelines, what 

should that different approach be? 

Authority: 28 U.S.C. 994(a), (o), (p), (x); 

USSC Rules of Practice and Procedure 4.4. 

William H. Pryor, Jr., 

Acting Chair. 

[FR Doc. 2017–21820 Filed 10–10–17; 8:45 am] 

BILLING CODE 2210–40–P 

DEPARTMENT OF VETERANS 

AFFAIRS 

[OMB Control No. 2900–0209] 

Agency Information Collection 

Activity: Application for Work Study 

Allowance; Student Work-Study 

Agreement (Advance Payment); 

Extended Student Work-Study 

Agreement; Student Work-Study 

Agreement 

AGENCY: Veterans Benefits 

Administration, Department of Veterans 

Affairs. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act (PRA) of 1995 

this notice announces that the Veterans 

Benefits Administration (VBA), 

Department of Veterans Affairs, will 

submit the collection of information 

abstracted below to the Office of 

Management and Budget (OMB) for 

review and comment. The PRA 

submission describes the nature of the 

information collection and its expected 

cost and burden; it includes the actual 

data collection instrument. 

DATES: Comments must be submitted on 

or before November 13, 2017. 

ADDRESSES: Submit written comments 

on the collection of information through 

www.Regulations.gov, or to Office of 

Information and Regulatory Affairs, 

Office of Management and Budget, Attn: 

VA Desk Officer; 725 17th St. NW., 

Washington, DC 20503 or sent through 

electronic mail to oira_submission@

omb.eop.gov. Please refer to ‘‘OMB 

Control No. 2900–0209’’ in any 

correspondence. 

FOR FURTHER INFORMATION CONTACT: 

Cynthia Harvey-Pryor, VA Clearance 

Officer—Office of Quality Privacy and 

Risk, Department of Veterans Affairs, 

810 Vermont Avenue NW., Washington, 

DC 20420, (202) 461–5870 or email 

Cynthia.harvey.pryor@va.gov. Please 

refer to ‘‘OMB Control No. 2900–0209’’ 

in any correspondence. 

SUPPLEMENTARY INFORMATION: 

Authority: Section 3485 of title 38, 

United States Code, and section 21.4145 

of title 38, Code of Federal Regulations 

necessitate these collections of 

information. 

Title: Application for Work Study 

Allowance; Student Work-Study 

Agreement (Advance Payment); 

Extended Student Work-Study 

Agreement; Student Work-Study 

Agreement (VA Forms 22–8691, 22– 

8692, 22–8692a, and 22–8692b). 

OMB Control Number: 2900–0209. 

Type of Review: Renewal of a 

currently approved collection. 

Abstract: VA uses the VA Forms 22– 

8691, 22–8692, 22–8692a, and 22–8692b 

collecting information to determine the 

individual’s eligibility for the workstudy allowance, the number of hours 

the individual will work, the amount 

payable, whether the individual desires 

an advance payment, and whether the 

individual wants to extend the workstudy contract. An agency may not 

conduct or sponsor, and a person is not 

required to respond to a collection of 

information unless it displays a 

currently valid OMB control number. 

The Federal Register Notice with a 60- 

day comment period soliciting 

comments on this collection of 

information was published at 82 FR 

35876 on August 1, 2017. 

Affected Public: Individuals and 

households. 

Estimated Annual Burden: 17,865 

hours. 

Estimated Average Burden per 

Respondent = 23 minutes. 

Frequency of Response: Once 

Annually. 

Estimated Number of Respondents: 

113,851. 

By direction of the Secretary. 

Cynthia Harvey-Pryor, 

VA Clearance Officer, Office of Quality 

Privacy and Risk, Department of Veterans 

Affairs. 

[FR Doc. 2017–21823 Filed 10–10–17; 8:45 am] 

BILLING CODE 8320–01–P 


asabaliauskas on DSKBBXCHB2PROD with NOTICES